AtriCure Reports Third-Quarter 2026 Financial Results
AtriCure announced its third-quarter 2026 financial results.
AtriCure, Inc. (NASDAQ:ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced third quarter 2026 financial results.“Our third quarter results demonstrate the strength…